Skip to content

To taste the Effect of Pepgard syrup in the patients of Hyper Acidity

Evaluation of efficacy and safety of pepgard syrup in comparision with Digene syrup in Amlapitta- an open labelled, randomized, two-arm, prospective, parallel clinical study.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/042136
Enrollment
36
Registered
2022-04-25
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K30- Functional dyspepsia

Interventions

None listed

Sponsors

Vital Care Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Presence of Pratyatmaka Lakshanas (cardinal symptoms) of Amlapitta such as Avipaka (indigestion) Klama (exhaustion without any exertion) Utklesha (nausea) Tikta-Amlodgara (erectations with bitter or sour taste) Gaurava (feeling of heaviness of the body) Hrit Kanthadaha burning sensation in the chest and throat) and Aruchi (loss of appetite) 2. Chronicity less than 1 year 3. Patients with gastritis gastric erosion

Exclusion criteria

Exclusion criteria: 1. Chronicity more than 1 year 2. Patients having any systemic disorders such as hypertension, diabetes 3. Patient with gastrointestinal complications such as peptic ulcer, duodenal ulcer, perforation, stenosis, bleeding, malena, and malignancy.

Design outcomes

Primary

MeasureTime frame
1. To evaluate the efficacy of Pepgard Syrup in the management of Amlapitta Patients on the basis of Amlapitta Symptoms Rating Scale. 2. To evaluate the efficacy of Digene syrup in the patients of Amlapitta on the basis of Amlapitta Symptoms Rating ScaleTimepoint: At the baseline, 30th day and 45th Day

Secondary

MeasureTime frame
TO compare the efficacy of Pepgard Syrup and Digene syrup in the management of Amlapitta Patients on the basis of Amlapitta Symptoms Rating ScaleTimepoint: At the baseline, 30th Day and 45th day

Countries

India

Contacts

Public ContactDr Naresh Kore

Parul Institute of Ayurved And Research

bhavin2490@gmail.com9033288715

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026